Transdermal buprenorphine offers analgesia similar to oral tramadol in post-spinal fusion management
Transdermal buprenorphine offers analgesia similar to oral tramadol in post-spinal fusion management
Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial
Eur Spine J. 2017 Nov;26(11):2961-2968Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
71 patients scheduled for single-level posterior lumbar interbody fusion were randomized to postoperative analgesia, beginning at 36 hours after surgery, with either transdermal buprenorphine patches or oral tramadol. Transdermal buprenorphine patch doses ranged from 5-20ug/hr and were replaced every 7 days, while oral tramadol doses ranged from 150-300mg daily. Patients were assessed for pain sco...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.